Target Name: ZNF767P
NCBI ID: G79970
Review Report on ZNF767P Target / Biomarker Content of Review Report on ZNF767P Target / Biomarker
ZNF767P
Other Name(s): Zinc finger family member 767, pseudogene, transcript variant 1 | ZNF767P variant 1 | zinc finger family member 767, pseudogene | ZNF767

ZNF767P: A Zinc Finger Family Member and Potential Drug Target

Zinc finger genes (ZFGs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZNF767P, a pseudogene and transcript variant 1, is one of the ZFGs that has gained significant interest due to its unique structure and gene expression patterns. This gene has been identified as a potential drug target or biomarker, which may offer new insights into the pathophysiology and treatment of various diseases.

Structure and Function

The ZNF767P gene is located at chromosome 11p36.1 and encodes a protein with a molecular weight of approximately 42 kDa. The protein is composed of 214 amino acid residues and has a calculated pI of 5.92. ZNF767P is a member of the Zinc Finger Gene (ZFG) family, which is characterized by the presence of a nucleotide-binding zinc finger and a C-terminal extension that includes a conserved domain and a unique amino acid sequence.

Functional Analysis

Several studies have demonstrated that ZNF767P is involved in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. ZNF767P has been shown to play a role in cell cycle progression by regulating the G1/S transition and cell division. The protein has been shown to interact with the cyclin D1 protein, which is involved in the G1/S transition.

Additionally, ZNF767P has been shown to be involved in apoptosis, which is a critical process for cell death and regulation. The protein has been shown to interact with the Bcl-2 protein, which is a protein that can induce and sustain apoptosis. This interaction suggests that ZNF767P may be involved in the regulation of apoptosis, which could have implications for the development of new therapeutic strategies for diseases such as cancer.

Drug Target Potential

The potential drug target for ZNF767P is its role in cell division and apoptosis. Drugs that target these processes, such as inhibitors of the cyclin D1 protein or Bcl-2 protein, may be effective in treating various diseases. For example, inhibitors of cyclin D1 have been shown to be effective in treating breast cancer and ovarian cancer. Similarly, inhibitors of Bcl-2 have been shown to be effective in treating various types of cancer.

Another potential approach to targeting ZNF767P is to modulate its expression levels. Drugs that interfere with the function of ZNF767P, such as small interfering RNA (siRNA), may be effective in reducing the expression of the protein and potentially reducing its levels in cancer cells.

Conclusion

ZNF767P is a unique pseudogene and transcript variant that has gained significant interest due to its structure and gene expression patterns. The protein has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. The potential drug target for ZNF767P is its role in cell division and apoptosis, which could offer new insights into the pathophysiology and treatment of various diseases. Further research is needed to fully understand the function and potential of ZNF767P as a drug target.

Protein Name: Zinc Finger Family Member 767, Pseudogene

The "ZNF767P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF767P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3